[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. - Wikidata - wikimedia - TriplyDB

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

http://www.wikidata.org/entity/Q53332122

about

Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes Imaging in pancreatic disease.Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.Dual-purpose linker for alpha helix stabilization and imaging agent conjugation to glucagon-like peptide-1 receptor ligands.A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator A modeling analysis of the effects of molecular size and binding affinity on tumor targeting.68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas.Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity.Efficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta Cells Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.Sphingomyelin patches on pancreatic beta-cells are indicative of insulin secretory capacity.Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors.Targets and probes for non-invasive imaging of β-cells.Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Radiometallated peptides for molecular imaging and targeted therapy.Radiopharmaceutical development of radiolabelled peptides.¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.Pancreatic β-cell imaging in humans: fiction or option?Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy.Radiolabeled peptides: valuable tools for the detection and treatment of cancer Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications.18F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster?Non-invasive monitoring of pancreatic tumor progression in the RIP1-Tag2 mouse by magnetic resonance imaging.

P2860

Q26766690-294C3B2B-BF9D-45BF-AB2B-76CCD6999EAA Q27025187-65CC54F5-C32B-4EDE-9EEC-E11CE53371B8 Q28067465-71883E5F-08B3-4727-812C-B6CD9272069E Q30275458-77740CF1-D912-45F9-8FB9-77E0B931497D Q30364628-D7699FB1-0C45-49AD-B44E-D35DA4F6FEBA Q30379845-37249BC2-FCA6-4356-A5E0-695086B8E392 Q33833281-CA4D6DDB-E958-46AC-8133-AD5B43C424A1 Q33835328-D4444585-6A53-4617-934C-7BB5C69356D9 Q33915233-7F8C0A2A-CE25-4C8B-80E6-67484D7E8CC4 Q34579936-E5AB1D78-326A-434A-8513-FDD88CF065E8 Q35087846-396EB022-1FC7-40DF-ACDB-6CA7E1F9E7AB Q35256800-04CEF7C5-C7E5-4E15-925D-122DE6EC4790 Q35402008-0BF9986F-B9B5-4E20-AC5A-476E09746DA6 Q35656591-B9F7F3D3-78B5-4640-8B9D-CAC456091B93 Q35794797-3F311D70-DCFB-4FDD-AEAD-8A974E8F1D1F Q36383709-632B7EAF-665B-42E5-B67B-277FA945055E Q36742916-7D9A7DB0-3059-4461-A571-0D9C1DFADD77 Q36903400-D1B029E8-0DEC-4E5F-95AB-5A6C0A764BC7 Q37116075-348D0264-4A67-4065-9B62-EFFC2D7B90A7 Q37134464-B26766F4-11C5-4A47-8E5D-4659081EC320 Q37188818-7DE83992-25CC-42F6-809A-113EEFC01D9C Q37343392-3A45D120-60F1-4C13-84E6-6976B5DB4A07 Q37607383-A4805077-B60C-4999-91FB-1A4201D549BD Q37662672-7C496C31-0D72-40CA-9CDF-418DFD5F2A88 Q37731335-492E7C06-F8E6-4853-BF10-52EE1E89615B Q37847064-0199FC25-F2FE-4DE4-AE68-095AFA792621 Q37990399-2ADCA13D-D356-4501-8938-582560F21E26 Q37990403-8B0E4526-4DAE-4191-8847-E50518300F7B Q38558006-CFAB7809-3481-44D6-9552-EBA8AE2B5544 Q38850036-8F454502-2E72-4D02-A6FB-711EBB54EA0E Q39596344-4E8A756A-20D7-4795-B507-FAB8C175FF5A Q42392588-BCED450D-88F4-4CAC-89F5-D18AF86268D1 Q42692487-4DA2CEAF-8C8C-4A50-B3D5-9961D235F727 Q46618702-7534D6E2-1AC9-4143-97D2-51BC07776ED3

P2860

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

http://www.wikidata.org/entity/Q53332122

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

[Lys40

@nl

[Lys40(Ahx-DTPA-111In)NH2]-Exe ...... rgeted therapy for insulinoma.

@en

type

label

[Lys40

@nl

[Lys40(Ahx-DTPA-111In)NH2]-Exe ...... rgeted therapy for insulinoma.

@en

prefLabel

[Lys40

@nl

[Lys40(Ahx-DTPA-111In)NH2]-Exe ...... rgeted therapy for insulinoma.

@en

P1433

Q53332122-E31C1BB7-D769-4F88-9BC7-5B38FA90D2E7

P1476

Q53332122-293320AA-B72A-4E8A-B5B7-3CD6A3BCBB3C

P2093

Q53332122-03C0232F-6CB2-4D9F-8101-9D755C328B9F

Q53332122-23E3441E-8372-4A77-9772-1B1B467A0A89

Q53332122-2D237441-019F-43F4-8BB5-19EAC9C23BDC

Q53332122-2EDBA385-E17F-4ECE-8AC2-B80CB10B7E58

Q53332122-463F67DE-9400-43FA-A42B-31FDDD47B65E

Q53332122-7271696E-94C3-4FD2-9CF4-3A68FAAD1575

Q53332122-7F9FC522-6ABB-4B53-9ACA-99C2B2B4E381

Q53332122-9938D1AE-C532-4482-8961-B211F59BFD13

Q53332122-9A5419C4-8282-4828-A530-E2F8BCD4EFC2

Q53332122-BBB3627D-A46F-4041-AC79-6F18F8A11008

P304

Q53332122-D72AE366-A56B-44D9-90D7-321FCBA12369

P31

Q53332122-3B872AED-60D1-4478-AC67-1ABEE6A0EDFB

P356

Q53332122-894FF57E-EBF1-412C-9DBF-AD52ADE7199F

P407

Q53332122-6BEDA014-0882-4A71-9D69-6D509A01AA28

P433

Q53332122-94C074C0-C2CE-42F5-A692-DCFCCC697F52

P478

Q53332122-2CE28CD7-8ADA-417B-BC7A-36084B8A6DA5

P50

Q53332122-F8272921-427F-464B-BFFD-19865F184AE4

P577

Q53332122-C534D26F-D7FF-4A83-A589-DDC6F4EBF427

P698

Q53332122-29F0C38C-D31B-4A76-99D4-EC850B9A45B5

P356

1078-0432.CCR-06-2965

P1433

Clinical Cancer Research

P1476

[Lys40(Ahx-DTPA-111In)NH2]-Exe ...... rgeted therapy for insulinoma.

@en

P2093

Christian Seemayer

http://www.w3.org/2001/XMLSchema#string

Damian Wild

http://www.w3.org/2001/XMLSchema#string

Daniel Storch

http://www.w3.org/2001/XMLSchema#string

Gerhard Christofori

http://www.w3.org/2001/XMLSchema#string

Helmut R Mäcke

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Reubi

http://www.w3.org/2001/XMLSchema#string

Martin Behe

http://www.w3.org/2001/XMLSchema#string

Martin Gotthardt

http://www.w3.org/2001/XMLSchema#string

Michael J Mihatsch

http://www.w3.org/2001/XMLSchema#string

Stefan Kneifel

http://www.w3.org/2001/XMLSchema#string

P304

3696-3705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-06-2965

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17575235

http://www.w3.org/2001/XMLSchema#string